Black Hawk Acquisition Corp (BKHAU)
Black Hawk Acquisition Corp operates as a blank check enterprise.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Shell Companies
Black Hawk Acquisition Corporation Units
+117.04%$17.45
Prev close$8.04-16.67%Open$6.70+160.45%Now$17.45
Mkt Cap$72.48M
EV$75.45M
Float3.63M
O/S4.15M
VOL67K sh
$ Vol$897K
RVOL18.28×
Inst Own-
SI<0.1%
Net Cash/Sh-$0.13
Dilution
MCap$72.48MFloat3.63MO/S4.15M
Dilution
Financials Summary
Revenue$0
Net Income$1.33M
Total Assets$23.88M
Free Cash Flow-$650K
Debt & Equity
Debt 3%
Equity 97%
Total Debt$595K
Total Equity$19.98M
Shares Outstanding
Short Interest
No short interest data available.
Split History
No splits on record
Nothing in BKHAU's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$23.88M
Liabilities$3.9M
Accounts Receivable$0
Accounts Payable$0
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-11-30 | 2024-11-30 | 2023-11-30 |
| Revenue | $0 | $0 | $0 |
| YoY Growth | - | - | - |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Gross Margin | - | - | - |
| Research and Development | $0 | $0 | $0 |
| Selling, General, and Administrative | $916K | $576K | $113K |
| Other | $0 | $0 | $0 |
| Total Operating Expenses | $916K | $576K | $113K |
| Operating Income (EBIT) | -$916K | -$576K | -$113K |
| Operating Margin | - | - | - |
| Interest Expense | $15K | $0 | $0 |
| Interest Income | $2.26M | $2.49M | $0 |
| Other Income (Expense) | $2.25M | $2.49M | $0 |
| Income Before Tax (EBT) | $1.33M | $1.92M | -$113K |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income | $1.33M | $1.92M | -$113K |
| Net Income Margin | - | - | - |
| Supplementary Data | |||
| EPS | 0.19 | 0.21 | -0.00 |
| Diluted EPS | 0.19 | 0.21 | -0.00 |
| Weighted Average OS | 5.00M | 8.93M | 8.93M |
| EBITDA | -$916K | -$576K | $0 |
| EBITDA Margin | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-11-30 | 2024-11-30 | 2023-11-30 |
| Assets | |||
| Current Assets | |||
| Cash and Cash Equivalents | $40K | $265K | $125K |
| Short-Term Investments | $0 | $0 | $0 |
| Cash and Short-Term Investments | $40K | $265K | $125K |
| Accounts Receivable | $0 | $0 | $31K |
| Inventory | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 |
| Total Current Assets | $51K | $314K | $156K |
| Long-Term Assets | |||
| Property, Plant & Equipment Net | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 |
| Long-Term Investments | $23.83M | $71.83M | $0 |
| Deferred Tax Assets | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $107K |
| Total Long-Term Assets | $23.83M | $71.83M | $107K |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $23.88M | $72.14M | $263K |
| Liabilities | |||
| Current Liabilities | |||
| Accounts Payable | $0 | $0 | $0 |
| Short-Term Debt | $595K | $0 | $250K |
| Current Income Tax Payable | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 |
| Total Current Liabilities | $1.48M | $71K | $257K |
| Long-Term Liabilities | |||
| Long-Term Debt | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 |
| Other Long-Term Liabilities | $2.42M | $2.42M | $0 |
| Total Long-Term Liabilities | $2.42M | $2.42M | $0 |
| Other Liabilities | $0 | $0 | $0 |
| Total Liabilities | $3.9M | $2.49M | $257K |
| Stockholders' Equity | |||
| Preferred Stock | $0 | $0 | $0 |
| Common Stock | $23.83M | $71.83M | $172 |
| Retained Earnings | -$3.85M | -$2.17M | -$19K |
| Comprehensive Income & Other | $0 | $0 | $0 |
| Other Stockholders' Equity | $5K | $0 | $25K |
| Total Equity | $19.98M | $69.66M | $6K |
| Minority Interest | $0 | $0 | $0 |
| Total Liabilities and Equity | $23.88M | $72.14M | $263K |
| Supplementary Data | |||
| Total Debt | $595K | $0 | $250K |
| Net Debt | $556K | -$265K | $125K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-11-30 | 2024-11-30 | 2023-11-30 |
| Operating Activities | |||
| Net Income | $1.33M | $1.92M | -$113K |
| Depreciation & Amortization | $0 | $0 | $113K |
| Deferred Income Tax | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $0 |
| Changes in Working Capital: | |||
| Accounts Receivable | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 |
| Other Working Capital | $279K | $15K | $41K |
| Total Working Capital Change | $279K | $15K | $41K |
| Other Non-Cash Items | -$2.26M | -$2.48M | -$44K |
| Net Cash from Operating | -$650K | -$554K | -$3K |
| Investing Activities | |||
| Capital Expenditures | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 |
| Purchases of Investments | $0 | -$69.34M | $0 |
| Sales of Investments | $0 | $0 | $0 |
| Other Investing Activities | $50.26M | $0 | -$31K |
| Net Cash from Investing | $50.26M | -$69.34M | -$31K |
| Financing Activities | |||
| Debt Repaid | - | - | - |
| Common Stock Issuance | $0 | $72.05M | -$91K |
| Common Stock Repurchases | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Financing Activities | -$49.84M | -$1.76M | $0 |
| Net Cash from Financing | -$49.84M | $70.04M | $159K |
| Forex Effect | $0 | $0 | $0 |
| Net Change in Cash | -$225K | $140K | $125K |
| Supplementary Data | |||
| Operating Cash Flow | -$650K | -$554K | -$3K |
| Capital Expenditure | $0 | $5 | $0 |
| Free Cash Flow | -$650K | -$554K | -$3K |
| Cash at Beginning | $265K | $125K | $0 |
| Cash at End | $40K | $265K | $125K |